Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review

Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review

Authors: Yeganeh Naderi1 | Maryam Rad1 | Ali Sadatmoosavi2 | Elham Khaleghi2 | Zahra Khorrami3 | Goli Chamani4 | Mohammad Shabani
Publication: Clinical and Experimental Dental Research
Year: 2024
View Article

The Facial Pain Research Foundation, Inc
2653 SW 87th Drive Suite A
Gainesville FL 32608-9313

Mailing address for Donations and all other correspondences:
4591 W. Higgins Road, Suite 703
Hoffman Estates, IL 60192

info@facingfacialpain.org

Nonprofit 501(c)3 Tax exempt organization. Gifts are tax deductible to the amount allowed by law. EIN 82-1317992

Get Updates On Our Research!

By submitting this form, you are consenting to receive marketing emails from: The Facial Pain Research Foundation. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Go to Top